Australia & New Zealand Stem Cell Market Forecast 2022-2028

Australia & New Zealand Stem Cell Market Forecast 2022-2028KEY FINDINGS

The Australia & New Zealand stem cell market is anticipated to rise with a CAGR of 10.50% over the estimated period. While the base year considered for the market study is 2021, the forecast years are from 2022 to 2028. The market growth of the country is driven by key factors such as increasing healthcare expenditure as well as favorable government support.

MARKET INSIGHTS

In 2019, the University of Melbourne and Stem Cells Australia was granted $104.65 million by the federal government for congenital heart diseases, stroke, dementia, blindness, and kidney diseases. Moreover, they also received $2.09 million for the advancement of stem cell research directed toward novel treatments in the year 2018. As a result, favorable government support and assistance for both firms and universities play an essential role in positively influencing the country’s market growth.

On the other hand, the public health system in New Zealand has been providing stem cell bone marrow transplants for several years, especially for patients with cancer. In addition, a collection of private clinics has also been established in the country. These medical facilities offer stem cell treatments to patients suffering from various conditions, such as joint problems, auto-immune diseases, sports injuries, and neurological problems. Hence, owing to the aforementioned factors, the stem cell market in Australia & New Zealand is anticipated to progress at a steady rate over the forecasted years.

COMPETITIVE INSIGHTS

Key companies operating in the market include Corning Inc, Merck KGaA (Sigma Aldrich), GE Healthcare, etc.

Our report offerings include:

• Explore key findings of the overall market

• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

• Market Segmentation caters to a thorough assessment of key segments with their market estimations

• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Key Growth Enablers
2.5. Key Challenges
3. Key Analytics
3.1. Impact Of Covid-19 On Stem Cell Market
3.2. Key Market Trends
3.3. Pestle Analysis
3.4. Porter’s Five Forces Analysis
3.4.1. Buyers Power
3.4.2. Suppliers Power
3.4.3. Substitution
3.4.4. New Entrants
3.4.5. Industry Rivalry
3.5. Opportunity Matrix
3.6. Vendor Landscape
3.7. Value Chain Analysis
3.8. Key Buying Criteria
3.8.1. Price
3.8.2. Efficacy
3.8.3. Application And Effectiveness
3.8.4. Accuracy
3.9. Regulatory Framework
4. Market By Therapeutic Application
4.1. Orthopedic Treatments
4.2. Injuries & Wounds
4.3. Oncology Disorders
4.4. Cardiovascular Disorders
4.5. Neurological Disorders
4.6. Diabetes
4.7. Other Therapeutic Applications
5. Market By Product
5.1. Adult Stem Cell
5.1.1. Hematopoietic Stem Cell
5.1.2. Neural Stem Cell
5.1.3. Umbilical Cord Stem Cell
5.1.4. Mesenchymal Stem Cell
5.1.5. Dental Stem Cell
5.2. Human Embryonic Stem Cell
5.3. Pluripotent
5.4. Mouse/Rat Neural
6. Market By Technology
6.1. Cell Acquisition
6.1.1. Bone Marrow Harvest
6.1.2. Umbilical Cord
6.1.3. Apheresis
6.2. Cell Production
6.2.1. Therapeutic Cloning
6.2.2. In Vitro Fertilization (Ivf)
6.2.3. Cell Culture
6.2.4. Isolation
6.3. Cryopreservation
6.4. Expansion & Sub-culture
7. Market By Application
7.1. Regenerative Medicine
7.2. Drug Discovery And Development
8. Market By Treatment Type
8.1. Allogeneic Stem Cell Therapy
8.2. Autologic Stem Cell Therapy
8.3. Syngeneic Stem Cell Therapy
9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Acquisitions
9.1.2. Partnerships
9.2. Company Profiles
9.2.1. Corning Inc
9.2.2. Ge Healthcare
9.2.3. Merck Kgaa (Sigma Aldrich)
9.2.4. Qiagen
9.2.5. Smith+Nephew Plc
9.2.6. Takara Holdings Inc
9.2.7. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings